Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neoplasm that affects the thymus. Representative examples include thymoma and carcinoma.
14 clinical trials registered, 7 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and medical devices. Pipeline includes 1 PHASE3, 2 PHASE2, 3 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05918302](https://clinicaltrials.gov/study/NCT05918302) |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 4:55 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. |
PHASE3 |
Grupo Espanol de Tumores Neuroendocrinos |
RECRUITING |
[NCT02012699](https://clinicaltrials.gov/study/NCT02012699) | Integrated Cancer Repository for Cancer Research | — | University of Nebraska | RECRUITING |
[NCT06996249](https://clinicaltrials.gov/study/NCT06996249) | Prospective Data Collection Initiative on Thoracic Malignancies | — | Dutch Society of Physicians for Pulmonology and Tuberculosis | RECRUITING |
[NCT04822077](https://clinicaltrials.gov/study/NCT04822077) | Study on Proton Radiotherapy of Thymic Malignancies | NA | Ass. Prof. Jan Nyman | RECRUITING |
[NCT05683886](https://clinicaltrials.gov/study/NCT05683886) | A Study of KC1036 in Patients with Advanced Thymic Tumors | PHASE2 | Beijing Konruns Pharmaceutical Co., Ltd. | RECRUITING |
12 publications have been identified in PubMed for thymus neoplasm. Research spans Case Report / Case Series (50%), Basic Science / Preclinical (25%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 50% |
Laboratory research | 3 | 25% |
Research summaries | 2 | 17% |
New treatment approaches | 1 | 8% |
Tang TY (2026). [PMID: 41946119](https://pubmed.ncbi.nlm.nih.gov/41946119/). *Mol Pharmacol*. [Basic Science / Preclinical]
Hossain MA (2025). [PMID: 41153776](https://pubmed.ncbi.nlm.nih.gov/41153776/). *Biomedicines*. [Case Report / Case Series]
Buchalska B (2025). [PMID: 40426858](https://pubmed.ncbi.nlm.nih.gov/40426858/). *Biomedicines*. [Review / Meta-Analysis]
Muro R (2025). [PMID: 40464763](https://pubmed.ncbi.nlm.nih.gov/40464763/). *Immunological reviews*. [Basic Science / Preclinical]
Sato T (2025). [PMID: 41035587](https://pubmed.ncbi.nlm.nih.gov/41035587/). *Cureus*. [Case Report / Case Series]
Niu Y (2025). [PMID: 40437606](https://pubmed.ncbi.nlm.nih.gov/40437606/). *Journal of cardiothoracic surgery*. [Gene Therapy / Novel Therapeutics]
Jóźwik-Plebanek K (2025). [PMID: 40331836](https://pubmed.ncbi.nlm.nih.gov/40331836/). *Endokrynologia Polska*. [Case Report / Case Series]
Whaley RD (2024). [PMID: 38970735](https://pubmed.ncbi.nlm.nih.gov/38970735/). *Endocr Pathol*. [Case Report / Case Series]
Giesen C (2024). [PMID: 39448408](https://pubmed.ncbi.nlm.nih.gov/39448408/). *Virchows Archiv : an international journal of pathology*. [Basic Science / Preclinical]
Zhu K (2024). [PMID: 38828408](https://pubmed.ncbi.nlm.nih.gov/38828408/). *Frontiers in endocrinology*. [Case Report / Case Series]